These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7316263)

  • 1. Cardiac conduction and rhythm disturbances following suicidal ingestion of mesoridazine.
    Niemann JT; Stapczynski JS; Rothstein RJ; Laks MM
    Ann Emerg Med; 1981 Nov; 10(11):585-8. PubMed ID: 7316263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid death resulting from mesoridazine overdose.
    Vertrees JE; Siebel G
    Vet Hum Toxicol; 1987 Feb; 29(1):65-7. PubMed ID: 3824877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxic manifestations of mesoridazine overdose.
    Marrs-Simon PA; Zell-Kanter M; Kendzierski DL; Leikin JB
    Ann Emerg Med; 1988 Oct; 17(10):1074-8. PubMed ID: 3177997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful suicides with thioridazine and mesoridazine: a result of probable cardiotoxicity.
    Donlon PT; Tupin JP
    Arch Gen Psychiatry; 1977 Aug; 34(8):955-7. PubMed ID: 889420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
    Dallaire S
    CMAJ; 2001 Jan; 164(1):91, 95. PubMed ID: 11202679
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drugs acting on the heart-conductive system in suicide attempts].
    Dabek J; Stachoń K; Jakubowski D; Rychlik W
    Pol Merkur Lekarski; 2012 Aug; 33(194):90-6. PubMed ID: 23009006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with mesoridazine and thioridazine in chronic schizophrenia: II. Potential predictors of drug response.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):527-32. PubMed ID: 720037
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs.
    Fowler NO; McCall D; Chou TC; Holmes JC; Hanenson IB
    Am J Cardiol; 1976 Feb; 37(2):223-30. PubMed ID: 2004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias.
    Fletcher GF; Kazamias TM
    Am Heart J; 1969 Jul; 78(1):135-8. PubMed ID: 5794785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effective intracavitary pacemaking for Taxus baccata-induced cardiac conduction defects and arrhythmias].
    Łukasik-Głebocka M; Sieńko A; Klimaszyk D; Mańkowski W
    Przegl Lek; 2007; 64(4-5):298-300. PubMed ID: 17724890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracardiac conduction defects following overdose of tricyclic antidepressant drugs.
    Vohra J; Hunt D; Burrows G; Sloman G
    Eur J Cardiol; 1975 Apr; 2(4):443-52. PubMed ID: 1126353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic changes following intravenous administration of thioridazine to macaque monkeys.
    Moore RH; Rainey JM
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):41-3. PubMed ID: 7076640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoridazine -- a pharmacodynamic and pharmacokinetic profile.
    Gershon S; Sakalis G; Bowers PA
    J Clin Psychiatry; 1981 Dec; 42(12):463-9. PubMed ID: 7031039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by mild hypothermia of ventricular conduction disturbances and reentrant arrhythmias induced by bupivacaine in dogs.
    Freysz M; Timour Q; Mazze RI; Bertrix L; Cohen S; Samii K; Faucon G
    Anesthesiology; 1989 May; 70(5):799-804. PubMed ID: 2719314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and severity of arrhythmias and conduction disturbance after repair of tetralogy of Fallot.
    Günal N; Tokel K; Kahramanyol O; Ozer S; Celiker A; Ekici E; Yurdakul Y; Kutsal A
    Turk J Pediatr; 1997; 39(4):491-8. PubMed ID: 9433151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive poisoning by naftidrofuryl with severe disorders of rhythm and conduction].
    Rey JL; Marek A; Tribouilloy C; Jarry G; Slama MA; Avinée P; Quiret JC; Bernasconi P
    Arch Mal Coeur Vaiss; 1989; 82(8):1467-71. PubMed ID: 2508601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac conduction abnormalities and atrial arrhythmias associated with salicylate toxicity.
    Mukerji V; Alpert MA; Flaker GC; Beach CL; Weber RD
    Pharmacotherapy; 1986; 6(1):41-3. PubMed ID: 3952006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.